Warby Parker (WRBY) Other Non-Current Liabilities (2020 - 2026)
Warby Parker's (WRBY) quarterly Other Non-Current Liabilities came in at $1.6 million in Q1 2026, up 23.14% YoY from $1.3 million in Q1 2025, and up 19.85% on a QoQ basis from $1.3 million in Q4 2025.
Warby Parker (WRBY) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Other Non-Current Liabilities data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 23.14% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 23.14% YoY) and the FY2025 annual result came in at $1.3 million, up 38.92% from the prior year.
- Other Non-Current Liabilities grew to $1.6 million in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $2.2 million in Q1 2022 to a low of $943000.0 in Q4 2024.
- A 5-year average of $1.4 million and a median of $1.3 million in 2025 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities sank 31.94% — and 2025, when it jumped 38.92%.
- Tracing WRBY's Other Non-Current Liabilities over 5 years: stood at $1.7 million in 2022, then dropped by 24.4% to $1.3 million in 2023, then dropped by 25.4% to $943000.0 in 2024, then surged by 38.92% to $1.3 million in 2025, then increased by 19.85% to $1.6 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $1.6 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.41 Mn |
| Mar 31, 2026 | 1.57 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 943,000.00 |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Dec 31, 2022 | 1.67 Mn |
| Sep 30, 2022 | 1.82 Mn |
| Jun 30, 2022 | 1.93 Mn |
| Mar 31, 2022 | 2.22 Mn |
| Sep 30, 2021 | 2.67 Mn |
| Dec 31, 2020 | 3.01 Mn |